Search
for
Sort by
Research 31–60 of 1000+
- Rumpel-Leede Phenomenon Associated with Pneumatic Compression: A Case Report
- Drug news and therapeutic news
- BH08 Unprovoked pulmonary emboli in a patient with alopecia areata treated with ritlecitinib: a case report
- French administrative health care database (SNDS): The value of its enrichment
- Cushing's syndrome in the elderly: data from the European Registry on Cushing's syndrome
- Ethinylestradiol/Chlormadinone Acetate
- MANAGING ESTROGEN-DEFICIENT SKIN: A NARRATIVE REVIEW ON THE ROLE OF HRT AND EMERGING ESTROGEN-MODULATING THERAPIES
- Polycystic ovary syndrome in North America
- Current aspects of polycystic ovary syndrome II: treatment of hyperandrogenism, insulin resistance and infertility
- Essentials of Aesthetic Surgery Jeffery J. Janis
- Poster 149 Rehabilitation, Functional Status Relationship to Re‐hospitalization Rates in Patients with Hematologic Malignancy after Hematopoietic Stem Cell Transplant
- Sex hormones and related compounds, including hormonal contraceptives
- This Week in JAMA
- Contraception for the 21st Century
- Enoxaparin-induced alopecia in patients with cerebral venous thrombosis
- Endocrinology of Transgender Medicine
- Contraception and the dermatologist
- Women’s Health Considerations for Lipid Management
- Rheumatologic Manifestations of Pregnancy
- The skin and obesity
- Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
- Cyclosporine-A-Induced Intracranial Thrombotic Complications: Systematic Review and Cases Report
- Thrombolytic Activity and Protein Characterization of Extract from White Oyster Mushroom (Pleurotus ostreatus)
- THE PEDIATRICIAN AND THE SEXUALLY ACTIVE ADOLESCENT
- Mendelian randomization studies of testosterone exposure: A systematic review
- Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2
- The Multiple Consequences of Obesity
- WARFARIN-INDUCED ALOPECIA: A RARE CASE REPORT
- The combination of ethinylestradiol/cyproterone acetate is temporarily withdrawn from the market in France. Is the measure justified?
- Update: baricitinib for alopecia areata